ADAC Announces Joint Program with P.E.T.Net to Advance New Cancer Detection Modality; ADAC Molecular Coincidence Detection Represents a Breakthrough in the Ability to Diagnose and Stage Cancer.
Linked as:
Extract
ADAC Announces Joint Program with P.E.T.Net to Advance New Cancer Detection Modality; ADAC Molecular Coincidence Detection Represents a Breakthrough in the Ability to Diagnose and Stage Cancer.
MILPITAS, Calif.--(BUSINESS WIRE)--June 4, 1996--ADAC Laboratories (NASDAQ:ADAC) and P.E.T.Net(TM) Pharmaceutical Services(TM), LLC, the newly formed joint venture between Syncor International Corporation (NASDAQ:SCOR) and CTI, Services, Inc., announc...
See the full content of this document
Sponsored links
